DRX NTX OR, OSTEOMARK NTX DIRECT RESPONSE

Enzymatic Method, Creatinine

METRIKA, INC.

The following data is part of a premarket notification filed by Metrika, Inc. with the FDA for Drx Ntx Or, Osteomark Ntx Direct Response.

Pre-market Notification Details

Device IDK984530
510k NumberK984530
Device Name:DRX NTX OR, OSTEOMARK NTX DIRECT RESPONSE
ClassificationEnzymatic Method, Creatinine
Applicant METRIKA, INC. 575 Shirlynn Court Los Altos,  CA  94022
ContactErika B Ammirati
CorrespondentErika B Ammirati
METRIKA, INC. 575 Shirlynn Court Los Altos,  CA  94022
Product CodeJFY  
CFR Regulation Number862.1225 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1998-12-21
Decision Date1999-08-10
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.